Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-06 Nussbaum Ran Director Option exercise · Stock Option (right to buy) −1,030 0
2022-06-06 Nussbaum Ran Director Option exercise +1,030 $5.00 $5K 1,433,928
2022-06-06 Nussbaum Ran Director Option exercise · Stock Option (right to buy) −1,030 0
2022-03-25 Kim Dong Chief Financial Officer Grant or award · Stock Option (right to buy) +20,000 20,000

Page 13 of 13 · 244 trades